Moneycontrol PRO

business

Dr Reddy's gets 13 USFDA observations for Duvvada plant

The Duvvada site manufactures cytotoxic and hormonal injectables and is an important plant given Dr Reddy‘s focus on complex generic filings. The Unit-7 received had warning letter in November 2015.

first published: Mar 8, 2017 08:57 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347